W. McNicholas (Dublin, Ireland), S. Frent (Arad, Romania), A. Sajnic (Zagreb, Croatia), J. Verbraecken (Edegem (Antwerp), Belgium)
Influence of anxious depressive disorder in the treatment of Sleep Apnea Hypopnea Syndrome
S. CEDEÑO DE JESUS (Sevilla, Spain), V. Almadana (Sevilla, Spain), J. Sánchez Gómez (Sevilla, Spain), A. Valido Morales (Sevilla, Spain), J. Benitez Moya (Sevilla, Spain)
|  |
MARITAL QUALITY, PARTNERS ENGAGEMENT AND CONTINOUS POSITIVE AIRWAY PRESSURE ADHERENCE IN OBSTRUCTIVE SLEEP APNEA
T. Gentina (Lille, France), S. Bailly (Grenoble, France), F. Jounieaux (Lille, France), F. Codron (Lille, France), C. Lamblin (Lille, France), C. Verkindre (Béthune, France), P. Broussier (Bois Guillaume, France), D. Guffroy (Maubeuge, France), A. Prigent (Rennes, France), J. Gres (Le Havre, France), L. Kedziora (Denin, France), J. Kabbani (Chelles, France), B. Douay (Lille, France), R. Tamisier (Grenoble, France), E. Gentina (Lille, France), J. Pepin (Grenoble, France)
| |
Erratic adherence to continuous positive airway pressure for obstructive sleep apnea
D. López-Padilla (Madrid, Spain), M. Llanos Flores (Madrid, Spain), V. Gallo González (Madrid, Spain), Z. Ji (Madrid, Spain), J. Terán Tinedo (Madrid, Spain), E. R. Jimeno (Madrid, Spain), S. López Martín (Madrid, Spain), E. Ojeda Castillejo (Madrid, Spain), L. Puente Maestu (Madrid, Spain)
| |
Assessing an auto set trial period for obstructive sleep apnoea patients
J. Topham (Nottingham, United Kingdom), L. Watson (Nottingham, United Kingdom), L. Johnson (Nottingham, United Kingdom), P. Smith (Nottingham, United Kingdom)
| |
Mild OSAS: Is CPAP therapy actually required for these patients?
S. Bansal (Mumbai, India), K. Utpat (Mumbai, India), U. Desai (Mumbai, India), J. Joshi (Mumbai, India)
| |
Prevalence of co-morbidities and clinical features in patients with obstructive sleep apnea and chronic obstructive pulmonary disease.
L. Spicuzza (CATANIA, Italy), E. Frasca (CATANIA, Italy), G. Doria (cATANIA, Italy), G. Cacopardo (CATANIA, Italy), C. Crimi (CATANIA, Italy), R. Campisi (CATANIA, Italy), N. Crimi (CATANIA, Italy), G. Di Maria (CATANIA, Italy)
| |
Prevalence of overlap of COPD and OSAS in a Pulmonary Rehabilitation Centre
A. Schreiber (Pavia, Italy), F. Cemmi (Peschiera del Garda (Verona), Italy), C. Lastoria (Pavia, Italy), P. Ceriana (Pavia, Italy), A. Balestrino (Pavia, Italy), A. Carlucci (Pavia, Italy)
|  |
Asthma and Obstructive Sleep Apnea Syndrome (OSAS)
F. Chaouki (Batna, Algeria), A. Djebbar (Batna, Algeria)
| |
Overlap syndrome "asthma and obstructive sleep apnea" in obese patients
F. Yangui (La Marsa. Tunis. , Tunisia), S. Ammari (La Marsa. Tunis. , Tunisia), H. Mrassi (La Marsa. Tunis. , Tunisia), I. Kharrat (La Marsa. Tunis. , Tunisia), M. Abouda (La Marsa. Tunis. , Tunisia), M. Charfi (La Marsa. Tunis. , Tunisia)
| |
Prevalence of obstructive sleep apnea in asthmatic school-aged children
H. Shafiek (Egypt), N. Fawzy (Egypt), M. Ibrahim Mahmoud (Egypt)
| |
OSA phenotypes in asthma and COPD
A. Priya (Delhi, India), N. Goel (Delhi, India), R. Kumar (Delhi, India)
| |
One airway one disease from a different perspective – eyes cant see what the mind doesn’t know
F. A Hakkim (Mangalore, India), R. V (Mangalore, India), G. B.H (Mangalore, India), N. Baikunje (Mangalore, India)
| |
IMPACT OF COMORBIDITY ON SLEEP QUALITY IN COPD PATIENTS EVALUATED WITH THE PITTSBURGH SLEEP QUALITY INDEX (PSQI)
J. Sampol Sirvent (Barcelona, Spain), P. Lloberes Canadell (Barcelona, Spain), O. Romero Santo Tomás (Barcelona, Spain), B. Valeiro González (Barcelona, Spain), M. Miravitlles Fernández (Barcelona, Spain), G. Sampol Rubio (Barcelona, Spain), J. Ferrer Sancho (Barcelona, Spain)
| |
Is OSA an important risk factor for metabolic dysregulation in obese COPD patients
S. Weber (Botucatu, Brazil), F. Pissulin (Botucatu, Brazil), R. Beneti (Presidente Prudente, Brazil), F. Pacagnelli (Presidente Prudente, Brazil)
| |
Assessment of 10-year risk for cardiovascular disease in patients with overlap syndrome
A. Voulgaris (Alexandroupolis, Greece), K. Archontogeorgis (Alexandroupolis, Greece), E. Nena (Alexandroupolis, Greece), M. Xanthoudaki (Alexandroupolis, Greece), P. Ntolios (Alexandroupolis, Greece), T. Mouemin (Alexandroupolis, Greece), K. Chadia (Alexandroupolis, Greece), N. Paxinou (Alexandroupolis, Greece), K. Kaltsas (Alexandroupolis, Greece), M. Froudarakis (Alexandroupolis, Greece), P. Steiropoulos (Alexandroupolis, Greece)
| |
Mean platelet volume and platelet distribution width in patients with obstructive sleep apnea syndrome and chronic obstructive pulmonary disease (overlap syndrome)
A. Voulgaris (Alexandroupolis, Greece), K. Archontogeorgis (Alexandroupolis, Greece), E. Nena (Alexandroupolis, Greece), M. Xanthoudaki (Alexandroupolis, Greece), P. Ntolios (Alexandroupolis, Greece), M. Kouratzi (Alexandroupolis, Greece), S. Anevlavis (Alexandroupolis, Greece), M. Froudarakis (Alexandroupolis, Greece), P. Steiropoulos (Alexandroupolis, Greece)
| |
Retinal vascular tortuosity in patients with obstructive sleep apnea-chronic obstructive pulmonary disease overlap syndrome
M. Yousif (Shebin Elkom, Egypt), R. El- Wahsh (Shebin Elkom, Egypt), A. Ibrahim (Shebin Elkom, Egypt)
| |
Role of intermittent or continuous hypoxia in systemic inflammation measured by echography
C. Acosta Gutierrez (Madrid, Spain), P. Landete Rodriguez (Madrid, Spain), B. Aldave Orzaiz (Madrid, Spain), M. Hernandez Olivo (Madrid, Spain), M. Gonzalez Gonzalez (Madrid, Spain), A. Sanchez Azofra (Madrid, Spain), A. Gonzalez Rodriguez (Madrid, Spain), E. Zamora Garcia (Madrid, Spain), J. MuñOz Olmedo (Madrid, Spain), A. Friera Reyes (Madrid, Spain), J. Soriano (Madrid, Spain), C. Garcia Monzon (Madrid, Spain), J. Ancochea Bermudez (Madrid, Spain)
| |
Case series: efficacy and usefulness of double bronchodilation in patiens with Overlap syndrome (OSAS and COPD).
A. Petrone (Cosenza, Italy), F. Fimognari (Cosenza, Italy), M. Quartieri (Cosenza, Italy), F. Mormile (Roma, Italy), L. Fuso (Roma, Italy), L. Petrone (Cosenza, Italy), F. Romano (Cosenza, Italy)
| |